T

Tyra Biosciences

Develops precision oncology therapies targeting FGFR

Associate Director - Global Supply Chain, CMC

Supply Chain ManagementUpdated on Nov 10
Full-timeRemote in USA$188.8k - $205.4k

About the Job

Requirements

  • A bachelor's degree in Supply Chain Operations, Business, Engineering, Life Sciences, Pharmacy, or a related field is required.
  • A minimum of 8 years of relevant experience in pharmaceutical, biotechnology, or clinical supply operations is required.
  • Demonstrated experience leading global clinical supply activities for complex clinical studies and development programs is required.
  • Strong expertise in clinical demand forecasting, inventory planning, supply strategy development, and risk management is required.
  • Hands-on experience with IRT systems, including design, implementation, testing, and study maintenance, is required.
  • Experience managing contract manufacturing organizations, clinical depots, logistics providers, packaging vendors, and other external service providers is required.
  • A strong understanding of global clinical packaging, labeling, distribution, logistics, inventory management, and reconciliation activities is required.
  • Working knowledge of global import/export requirements and customs regulations supporting clinical trials is required.
  • A strong understanding of GxP quality systems and applicable regulatory requirements is required.
  • Working knowledge of drug substance, drug product, stability, packaging, and other CMC activities that impact clinical supply strategy is required.
  • Candidates must be authorized to work in the United States.
  • The candidate must be able to travel domestically and internationally up to 10%.
  • The candidate must have excellent organizational skills and be able to prioritize effectively to deliver results within established timelines.
  • The candidate must be able to work independently and as part of a team.
  • Strong interpersonal skills, including verbal and written communication, are essential in this collaborative work environment.

Responsibilities

  • Lead development and execution of global clinical supply strategies for assigned clinical programs and studies.
  • Translate clinical protocols, enrollment assumptions, country activation plans, dosing regimens, and development timelines into comprehensive demand forecasts and supply plans.
  • Develop supply scenarios and risk assessments to support decisions related to enrollment variability, cohort expansion, formulation changes, manufacturing capacity, inventory levels, and expiry management.
  • Establish inventory, safety stock, resupply, and allocation strategies to ensure uninterrupted patient supply while minimizing waste and cost.
  • Evaluate supply implications associated with protocol amendments, country additions, enrollment changes, manufacturing delays, and regulatory requirements.
  • Support long-range planning by communicating clinical demand forecasts and supply requirements to CMC, manufacturing, and finance stakeholders.
  • Present supply risks, assumptions, mitigation plans, and recommendations to cross-functional program teams and senior leadership.
  • Serve as the clinical supply lead and primary point of accountability for assigned clinical studies and development programs.
  • Ensure clinical supply readiness for study startup, cohort initiations, country activations, interim study milestones, and study closeout activities.
  • Lead oversight of global packaging, labeling, storage, distribution, returns, reconciliation, destruction, and transportation activities.
  • Develop packaging and labeling strategies appropriate for study design, blinding requirements, country-specific regulations, and operational efficiency.
  • Oversee global inventory deployment and replenishment across depots, clinical sites, and direct-to-patient supply channels where applicable.
  • Monitor inventory levels, expiry timelines, shipment performance, and supply metrics to ensure continuity of supply throughout the clinical trial lifecycle.
  • Lead management of temperature excursions, shipment deviations, inventory discrepancies, and supply interruptions.
  • Lead the clinical supply workstream for IRT strategy, system design, implementation, testing, deployment, maintenance, and study closeout.
  • Collaborate with Clinical Operations, Data Management, Biostatistics, and external vendors to ensure successful system implementation and performance.
  • Monitor supply system performance and inventory data to proactively identify risks and optimize clinical supply strategies.
  • Support implementation and continuous improvement of forecasting, inventory management, and supply planning systems.
  • Ensure all clinical supply activities comply with applicable GxP requirements, internal procedures, quality agreements, and regulatory requirements.
  • Partner with Quality Assurance to investigate deviations, determine root causes, assess impact, and implement corrective and preventive actions.
  • Support inspection readiness and audit activities related to clinical supply operations.
  • Author, review, approve, and maintain SOPs, work instructions, supply plans, specifications, and other clinical supply documentation.
  • Provide subject matter expertise and operational support for regulatory submissions, health authority information requests, and clinical trial applications.
  • Oversee import/export readiness and ensure required permits, licenses, documentation, and customs requirements are maintained to support global trial execution.

Desired Qualifications

  • An advanced degree is preferred.
  • Experience supporting regulatory filings, audits, inspections, and health authority interactions is preferred.
  • Pharmaceutical development experience across multiple regions and multiple concurrent studies is preferred.

About the Company

Tyra Biosciences

Develops precision oncology therapies targeting FGFR

Tyra Biosciences develops precision medicines for cancer and genetically defined diseases using its SNAP platform to target specific genetic mutations. Its lead programs include TYRA-300, an FGFR3 inhibitor for achondroplasia and non-muscle invasive bladder cancer, and TYRA-200, an FGFR1/2/3 inhibitor for intrahepatic cholangiocarcinoma and other solid tumors. The SNAP platform supports mutation-focused drug design to overcome resistance and tailor therapies, aided by collaborations with academic partners to advance trials. Funding comes from venture capital and public offerings, with future revenue expected from drug sales and licensing upon regulatory approval, and the goal of bringing targeted, effective treatments to patients by moving candidates through clinical development toward commercialization.

Company size
51-200
Company stage
IPO
Headquarters
Carlsbad, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Tyra Biosciences

See more jobs